CA9 and hemoglobin measurement: We used a larger patient cohort [GSE131329, a dataset containing 53 HB and 14 normal liver samples] to compare CAIX mRNA expression with three clinical variables – occurrence of an unfavorable event, metastasis, and overall survival.